Skip to main content

Market Overview

The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows

The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows

Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online Thursday calling the shots. Earnings news flow continued to taper.

Biopharma companies working on vaccines/therapies for COVID-19 continued to provide updates. Novavax, Inc. (NASDAQ: NVAX) shares more than doubled, thanks to an announcement concerning a $384 million grant from the Coalition for Epidemic Preparedness Innovations.

Here are the key catalysts for the unfolding week.


  • UBS Virtual Global Healthcare Conference: May 18-20
  • RBC Capital Markets 2020 Global Healthcare Virtual Conference: May 19-20
  • European Society for Medical Oncology, or ESMO, Breast Cancer Virtual Meeting: May 23-24


The FDA is due to rule on Aquestive Therapeutics Inc's (NASDAQ: AQST) NDA for apomorphine sublingual film (APL-130277), which is being evaluated for treating off episodes in Parkinson's disease patients. APL-130277 is being developed by Sunovion Pharmaceuticals, a subsidiary of Sumitomo Dainippon Pharma, in partnership with Aquestive.

Clinical Readouts

Entera Bio Ltd (NASDAQ: ENTX) is scheduled to report on Thursday interim three-month top-line biomarker data for the first 50% of the patients enrolled in the Phase 2 osteoporosis clinical trial of EB613.

Oncolytics Biotech, Inc. (NASDAQ: ONCY) is due to present at the ESMO Breast Cancer Conference, interim biomarker data from the AWARE-1 early-stage breast cancer study that is evaluating its pelareorep along with Roche Holdings AG's (OTC: RHHBY) Tecentriq.

See Also: Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand



Milestone Scientific Inc. (NYSE: MLSS) (before the market open)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP) (after the close)


Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (after the close)
Ascendis Pharma A/S (NASDAQ: ASND) (after the close)


Mediwound Ltd (NASDAQ: MDWD) (before the market open)
China Biologic Products Holdings Inc (NASDAQ: CBPO) (after the close)


Entera Bio (before the market open)
Medtronic PLC (NYSE: MDT) (before the market open)
PAVmed Inc (NASDAQ: PAVM) (after the close)
Xenon Pharmaceuticals Inc (NASDAQ: XENE) (after the close)

IPO Quiet Period Expiry

ORIC Pharmaceuticals Inc (NASDAQ: ORIC)


Related Articles (XBI + IBB)

View Comments and Join the Discussion!

Posted-In: Biotech News Penny Stocks Health Care Previews FDA Top Stories Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at